Targeted depletion of TRBV9


Journal

Nature medicine
ISSN: 1546-170X
Titre abrégé: Nat Med
Pays: United States
ID NLM: 9502015

Informations de publication

Date de publication:
Nov 2023
Historique:
received: 22 06 2023
accepted: 26 09 2023
medline: 27 11 2023
pubmed: 24 10 2023
entrez: 23 10 2023
Statut: ppublish

Résumé

Autoimmunity is intrinsically driven by memory T and B cell clones inappropriately targeted at self-antigens. Selective depletion or suppression of self-reactive T cells remains a holy grail of autoimmune therapy, but disease-associated T cell receptors (TCRs) and cognate antigenic epitopes remained elusive. A TRBV9-containing CD8

Identifiants

pubmed: 37872223
doi: 10.1038/s41591-023-02613-z
pii: 10.1038/s41591-023-02613-z
pmc: PMC10667094
doi:

Substances chimiques

Epitopes 0
HLA-B Antigens 0
Receptors, Antigen, T-Cell 0
Tumor Necrosis Factor Inhibitors 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2731-2736

Informations de copyright

© 2023. The Author(s).

Références

Benjamin, R. & Parham, P. Guilt by association: HLA-B27 and ankylosing spondylitis. Immunol. Today 11, 137–142 (1990).
doi: 10.1016/0167-5699(90)90051-A pubmed: 2187471
Faham, M. et al. Discovery of T cell receptor beta motifs specific to HLA-B27-positive ankylosing spondylitis by deep repertoire sequence analysis. Arthritis Rheumatol. 69, 774–784 (2017).
doi: 10.1002/art.40028 pubmed: 28002888
Komech, E. A. et al. CD8+ T cells with characteristic T cell receptor beta motif are detected in blood and expanded in synovial fluid of ankylosing spondylitis patients. Rheumatology 57, 1097–1104 (2018).
doi: 10.1093/rheumatology/kex517 pubmed: 29481668
Pogorelyy, M. V. et al. Detecting T cell receptors involved in immune responses from single repertoire snapshots. PLoS Biol. 17, e3000314 (2019).
doi: 10.1371/journal.pbio.3000314 pubmed: 31194732 pmcid: 6592544
May, E. et al. Conserved TCR beta chain usage in reactive arthritis; evidence for selection by a putative HLA-B27-associated autoantigen. Tissue Antigens 60, 299–308 (2002).
doi: 10.1034/j.1399-0039.2002.600404.x pubmed: 12472659
Yang, X. et al. Autoimmunity-associated T cell receptors recognize HLA-B*27-bound peptides. Nature 612, 771–777 (2022).
doi: 10.1038/s41586-022-05501-7 pubmed: 36477533 pmcid: 10511244
Komech, E. A. et al. TCR repertoire profiling revealed antigen-driven CD8+ T cell clonal groups shared in synovial fluid of patients with spondyloarthritis. Front. Immunol. 13, 973243 (2022).
doi: 10.3389/fimmu.2022.973243 pubmed: 36325356 pmcid: 9618624
Garrido-Mesa, J. & Brown, M. A. T cell repertoire profiling and the mechanism by which HLA-B27 causes ankylosing spondylitis. Curr. Rheumatol. Rep. 24, 398–410 (2022).
doi: 10.1007/s11926-022-01090-6 pubmed: 36197645 pmcid: 9666335
Bowness, P. HLA-B27. Annu. Rev. Immunol. 33, 29–48 (2015).
doi: 10.1146/annurev-immunol-032414-112110 pubmed: 25861975
Chiocchia, G., Boissier, M. C. & Fournier, C. Therapy against murine collagen-induced arthritis with T cell receptor V beta-specific antibodies. Eur. J. Immunol. 21, 2899–2905 (1991).
doi: 10.1002/eji.1830211202 pubmed: 1836185
Liu, Z. et al. Prevention of type 1 diabetes in the rat with an allele-specific anti-T-cell receptor antibody: Vbeta13 as a therapeutic target and biomarker. Diabetes 61, 1160–1168 (2012).
doi: 10.2337/db11-0867 pubmed: 22368175 pmcid: 3331757
Paul, S. et al. TCR beta chain-directed bispecific antibodies for the treatment of T cell cancers. Sci. Transl. Med. 13, eabd3595 (2021).
doi: 10.1126/scitranslmed.abd3595 pubmed: 33649188 pmcid: 8236299
Maciocia, P. M. et al. Targeting the T cell receptor beta-chain constant region for immunotherapy of T cell malignancies. Nat. Med. 23, 1416–1423 (2017).
doi: 10.1038/nm.4444 pubmed: 29131157
Putintseva, E. V. et al. Mother and child T cell receptor repertoires: deep profiling study. Front. Immunol. 4, 463 (2013).
doi: 10.3389/fimmu.2013.00463 pubmed: 24400004 pmcid: 3872299
Xue, Z. et al. Disease associated human TCR characterization by deep-learning framework TCR-DeepInsight. Preprint at bioRxiv https://doi.org/10.1101/2023.05.22.541406 (2023).
Nakayama, M. & Michels, A. W. Using the T cell receptor as a biomarker in type 1 diabetes. Front. Immunol. 12, 777788 (2021).
doi: 10.3389/fimmu.2021.777788 pubmed: 34868047 pmcid: 8635517
Rosati, E. et al. A novel unconventional T cell population enriched in Crohn’s disease. Gut 71, 2194–2204 (2022).
doi: 10.1136/gutjnl-2021-325373 pubmed: 35264446
Valente, D. et al. Pharmacokinetics of novel Fc-engineered monoclonal and multispecific antibodies in cynomolgus monkeys and humanized FcRn transgenic mouse models. mAbs 12, 1829337 (2020).
doi: 10.1080/19420862.2020.1829337 pubmed: 33079615 pmcid: 7587234
Mamedov, I. Z. et al. Quantitative tracking of T cell clones after haematopoietic stem cell transplantation. EMBO Mol. Med. 3, 201–207 (2011).
doi: 10.1002/emmm.201100129 pubmed: 21374820 pmcid: 3377069
Britanova, O. V. et al. First autologous hematopoietic SCT for ankylosing spondylitis: a case report and clues to understanding the therapy. Bone Marrow Transpl. 47, 1479–1481 (2012).
doi: 10.1038/bmt.2012.44
Hayashi, F. et al. A new clustering method identifies multiple sclerosis-specific T-cell receptors. Ann. Clin. Transl. Neurol. 8, 163–176 (2021).
doi: 10.1002/acn3.51264 pubmed: 33400858 pmcid: 7818280
Sewell, A. K. Why must T cells be cross-reactive? Nat. Rev. Immunol. 12, 669–677 (2012).
doi: 10.1038/nri3279 pubmed: 22918468 pmcid: 7097784
Montalvao, F. et al. The mechanism of anti-CD20-mediated B cell depletion revealed by intravital imaging. J. Clin. Invest. 123, 5098–5103 (2013).
doi: 10.1172/JCI70972 pubmed: 24177426 pmcid: 3859399
Shugay, M. et al. Towards error-free profiling of immune repertoires. Nat. Methods 11, 653–655 (2014).
doi: 10.1038/nmeth.2960 pubmed: 24793455
Bolotin, D. A. et al. MiXCR: software for comprehensive adaptive immunity profiling. Nat. Methods 12, 380–381 (2015).
doi: 10.1038/nmeth.3364 pubmed: 25924071
Shugay, M. et al. VDJtools: unifying post-analysis of T cell receptor repertoires. PLoS Comput. Biol. 11, e1004503 (2015).
doi: 10.1371/journal.pcbi.1004503 pubmed: 26606115 pmcid: 4659587
Wickham, H. ggplot2: Elegant Graphics for Data Analysis 1st edn (Springer-Verlag, 2009).
doi: 10.1007/978-0-387-98141-3
Wagih, O. ggseqlogo: a versatile R package for drawing sequence logos. Bioinformatics 33, 3645–3647 (2017).
doi: 10.1093/bioinformatics/btx469 pubmed: 29036507

Auteurs

Olga V Britanova (OV)

Pirogov Russian National Research Medical University, Moscow, Russia.
Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia.

Kseniia R Lupyr (KR)

Pirogov Russian National Research Medical University, Moscow, Russia.
Skolkovo Institute of Science and Technology, Moscow, Russia.

Dmitry B Staroverov (DB)

Pirogov Russian National Research Medical University, Moscow, Russia.
Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia.

Irina A Shagina (IA)

Pirogov Russian National Research Medical University, Moscow, Russia.
Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia.

Alexey A Aleksandrov (AA)

BIOCAD, St. Petersburg, Russia.

Yakov Y Ustyugov (YY)

BIOCAD, St. Petersburg, Russia.

Dmitry V Somov (DV)

Pirogov Russian National Research Medical University, Moscow, Russia.

Alesia Klimenko (A)

Pirogov Russian National Research Medical University, Moscow, Russia.

Nadejda A Shostak (NA)

Pirogov Russian National Research Medical University, Moscow, Russia.

Ivan V Zvyagin (IV)

Pirogov Russian National Research Medical University, Moscow, Russia.
Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia.

Alexey V Stepanov (AV)

Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia.

Ekaterina M Merzlyak (EM)

Pirogov Russian National Research Medical University, Moscow, Russia.
Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia.

Alexey N Davydov (AN)

Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
MiLaboratories Inc., Sunnyvale, CA, USA.

Mark Izraelson (M)

MiLaboratories Inc., Sunnyvale, CA, USA.

Evgeniy S Egorov (ES)

Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia.
Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany.

Ekaterina A Bogdanova (EA)

Pirogov Russian National Research Medical University, Moscow, Russia.

Anna K Vladimirova (AK)

BIOCAD, St. Petersburg, Russia.

Pavel A Iakovlev (PA)

BIOCAD, St. Petersburg, Russia.

Denis A Fedorenko (DA)

Department of Hematology and Chemotherapy, Pirogov National Medical and Surgical Center, Moscow, Russia.

Roman A Ivanov (RA)

BIOCAD, St. Petersburg, Russia.

Veronika I Skvortsova (VI)

Pirogov Russian National Research Medical University, Moscow, Russia.
Federal Medical Biological Agency, Moscow, Russia.

Sergey Lukyanov (S)

Pirogov Russian National Research Medical University, Moscow, Russia.
Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia.

Dmitry M Chudakov (DM)

Pirogov Russian National Research Medical University, Moscow, Russia. chudakovdm@gmail.com.
Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia. chudakovdm@gmail.com.
Central European Institute of Technology, Masaryk University, Brno, Czech Republic. chudakovdm@gmail.com.
Abu Dhabi Stem Cell Center, Al Muntazah, United Arab Emirates. chudakovdm@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH